可溶性CTLA-4减弱T细胞激活,调节抗瘤免疫力
Paul T Kennedy1, Emma L Saulters1, Andrew D Duckworth2
1Department of Pharmacology and Therapeutics, University of Liverpool, L69 3GE Liverpool, UK.
概括
由瘤表达的可溶性CTLA-4 (sCTLA-4) 抑制了CD8+ T细胞. 用特定抗体向sCTLA-4可增强T细胞活性,控制瘤生长,从而揭示出新的免疫治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 细胞毒性T-淋巴细胞相关蛋白4 (CTLA-4) 是一个关键的免疫检查点受体,调节免疫反应.
- 针对CTLA-4的抗体用于癌症免疫疗法,但它们的确切机制尚不清楚.
- 可溶性变体sCTLA-4在癌症免疫力中的作用尚未研究.
研究的目的:
- 为了研究sCTLA-4在癌症中的功能作用.
- 评估使用异型特异性抗体向sCTLA-4的治疗潜力.
主要方法:
- 在体外测试以评估sCTLA-4对CD8+T细胞的影响.
- 在体内小鼠癌症模型评估瘤生长和转移.
- 针对sCTLA-4的异型特异性抗体治疗.
主要成果:
- 瘤表达的sCTLA-4在体外抑制了CD8+ T细胞的活性.
- sCTLA-4通过损害CD8+ T细胞细胞毒性功能,在体内加速瘤生长和转移.
- 用抗-sCTLA-4抗体治疗逆转了T细胞抑制,增强了抗瘤免疫力,并改善了瘤控制.
结论:
- 来自瘤的sCTLA-4在免疫逃避和瘤进展中起着重要作用.
- 向sCTLA-4代表了增强癌症免疫疗法的有希望的策略.
- 进一步阐明免疫检查点受体异型对于优化癌症治疗至关重要.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
143
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
143
T Cell Activation and Clonal Selection
743
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
743
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923


